小林 千明
パートナー
東京オフィスのマネージング・パートナー。化学、バイオテクノロジー、製薬分野を中心に、クライアントへの助言、特許出願、鑑定書の作成、デュー・デリジェンス、訴訟対応、さらには特許付与後異議申立手続に至るまで、知的財産法のあらゆる分野を幅広く手掛けている。
実績
Senju Pharmaceutical Co.; Bausch + Lomb v. Lupin Ltd.
Represented Senju and Bausch + Lomb in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic versions of Prolensa®. Secured a permanent injunction against generic defendants.
1:14-cv-00667, -04149; 1:15-cv-00335; 1:16-cv-01097, D.N.J., Judges Goodman, Shipp, Simandle, Williams
Secured a permanent injunction against generic defendants on behalf of Bausch + Lomb, Mitsubishi Tanabe, Ube, and Senju in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic versions of opthalmic drug Bepreve®.
1:14-cv-01325, D.N.J., Judges Arpert, Hillman, Schneider, Shipp
Successfully represented Bausch & Lomb and Eye Therapies in a Hatch-Waxman patent infringement litigation and parallel PTAB challenges concerning an ANDA for generic versions of over-the-counter Lumify® ocular drops. The cases settled favorably for our clients.
3:21-cv-16766, D.N.J., Judges Kirsch, Singh
IPR2022-00146, PTAB, Judges Hulse, New, Pollock
IPR2024-00467, PTAB, Judges Flax, Pollock, Yang
IPR2022-00142, PTAB, Judges Flax, Hulse, New, Pollock
Mitsubishi Tanabe Pharma Corporation v. Shanghai Auzone Biological Technology Co., Ltd et al.
Representing Mitsubishi Tanabe Pharma in litigation matters related to Radicava ORS (edaravone) used to treat patients with amyotrophic lateral sclerosis (ALS).
2:25-cv-03326, D.N.J., Judge Cecchi
1:23-cv-00759, D. Del., Judges Burke, Connolly, Hall
1:24-cv-01423, D. Del., Judge Hall
1:24-cv-00549, D. Del., Judge Hall
Commercial Copy Innovations, Inc. v. Mimaki USA, Inc. et al.
8:17-cv-00437, C.D. Cal., Judges Scott, Selna
Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.
2:15-cv-07971, D.N.J., Judges Bongiovanni, Chesler, Waldor
Insights
Event
October 30, 2025
Tokyo
Seminar
Evolving Patent Strategies: Recent PTAB Trends, AI Challenges, and Biotech Innovations
May 22, 2025
Tokyo
Webinar
Introductory Course on Reviewing English Language Contracts for Pharmaceutical Companies
January 29, 2025
Webinar
Professional Recognition
"Chiaki Kobayashi shines at prosecution, litigation and counselling, especially when it comes to biotechnology and pharmaceuticals. Among her professional highlights is securing a permanent injunction against generics."
最新情報
Award/Ranking
Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked
May 28, 2026
Intellectual Asset Management (IAM)Award/Ranking
50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000
June 2, 2025
Intellectual Asset Management (IAM)Award/Ranking
46 Finnegan Attorneys Ranked in 2024 IAM Patent 1000
June 6, 2024
Intellectual Asset Management (IAM)Press Release
Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked
June 30, 2023
Intellectual Asset Management (IAM)Professional Activities
- Licensing Executives Society of Japan (LESJ)
Admissions
- District of Columbia
- California
- Registered Foreign Attorney in Japan (Gaikokuho Jimu Bengoshi)
Education
- George Washington University Law School
- J.D., with honors, 2014
- Brandeis University
- B.S., Biochemistry, Economics, and Chemistry, magna cum laude, 2011
Languages
- Japanese
小林's Practices
- デュー・デリジェンス、ライセンシング、意見
- デューディリジェンス
- グローバルな知的財産権利の執行、訴訟、および裁判
- 特許訴訟および裁判 ― 簡略新薬承認申請 （ANDA）
- 特許訴訟および裁判
- 公判前戦略
- 特許庁における無効審判
- PTABにおける無効手続：当事者系レビューおよび特許付与後レビュー
- 特許出願及びポートフォリオ管理
- 特許明細書作成及び出願手続
小林's Industries
- 化学・工業・材料
- 化学
- ライフサイエンス
- Biotechnology
- 製薬